| Value | ₹2.09 Cr |
|---|
BSE filing, NSE: ATUL. Summary written from the filing by ALFA Finder's alert engine.
Atul Ltd: key numbers
- Share price
- ₹5,152.00
- Market cap
- ₹15,168 Cr
- Revenue (annual)
- ₹6,274 Cr
- Net profit (annual)
- ₹677.9 Cr
- P/E (TTM)
- 19.6×Sector 33.9×
- Promoter holding
- 45.33%+0.00% QoQ
- FII holding
- 8.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Atul Ltd
All →Atul Capital Structure Change
Atul bought back 12,600 shares on 3 November 2026 for ₹6.45 Crore. Cumulative buyback is 17,100 shares for ₹8.74 Crore against the ₹90 Crore earmark.
- Value
- ₹6.45 Cr
Atul Capital Structure Change
Atul Ltd submitted its daily buy-back report for 2 November 2026, with 4,500 shares bought back at an average price of Rs.5,072.37. Cumulative buy-back spend reached Rs.87.72 Crore of the Rs.90 Crore earmarked.
- Value
- ₹2.28 Cr
Atul Other Announcement
Atul Limited transferred 7,696 equity shares to the Investor Education and Protection Fund under Section 124(6) of the Companies Act. This is a routine statutory transfer of unclaimed shares with no financial or business impact.
Atul Capital Structure Change
Atul Limited announced an open market buyback of equity shares worth ₹200 Crore. Shares will be purchased via stock exchanges subject to regulatory compliance.
- Value
- ₹200.0 Cr
Atul Capital Structure Change
Atul's board approved a buyback of 1,20,000 equity shares at Rs 7,500 each, up to Rs 90 Crore. The buyback will be executed through the open market.
- Value
- ₹90.00 Cr
Atul Other Announcement
Atul Limited's board appointed Priyanshu Gundana as statutory auditor for 60 months from April 1, 2027. The filing states no monetary value.
- Execution
- 60 months from 2027-04-01
Other capital structure change announcements
All →Dr. Lal Pathlabs Capital Structure Change
Dr. Lal PathLabs will invest up to Rs 49.5 Crore in its wholly owned Dubai subsidiary, in tranches. Funds cover operations and further investment in Ghana's SHL.
- Value
- ₹49.50 Cr
- Execution
- Indicative completion by 31 March 2027, in tranches
Jenburkt Pharmaceuticals Capital Structure Change
Counter Cyclical Investments Private Limited acquired 4,608 equity shares of Jenburkt Pharmaceuticals Ltd through the open market. This acquisition increased the acquirer's total holding from 5.01% to 5.11%.
Premier Explosives Capital Structure Change
Rajasthan Global Securities sold 26,53,831 shares of Premier Explosives Ltd in the open market and offer. The sale reduced the non-promoter entity's stake from 5.90% to 0.08%.
Ola Electric Mobility Capital Structure Change
Promoter and Director Bhavish Aggarwal acquired 9,81,99,966 partly paid-up equity shares of Ola Electric Mobility Ltd for ₹1,590.84 Crore. The acquisition was executed via a rights issue allotment.
- Value
- ₹159.1 Cr
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Identixweb Capital Structure Change
NAV Capital Emerging Star Fund, a non-promoter, bought 48,000 Identixweb shares in the open market on 2 Nov 2026, lifting its stake to 5.11%. No per-share price or total consideration is disclosed.